by Leslie Small
Large employers are
increasingly leaning on their health plan and PBM partners to devise innovative
solutions to health care challenges, according to the 2020 Large Employers'
Health Care Strategy and Plan Design Survey conducted by the National Business
Group on Health (NBGH).
In the 2019 survey, 32%
of large employers said they would take a "defer to partners
approach" to drive health system change — implementing what their health
plan and PBM present as the latest developments. For 2020, that share rose to
41%.
NBGH attributes that
trend to a number of factors, Ellen Kelsay, NBGH's chief strategy officer, said
at a press briefing. One is that employers are "frustrated with the slow
pace of change" in health care and are looking to their partners to speed
it up. Most employers also lack the bandwidth to drive change on their own, she
said.
What's more, "many
employers are looking for a way to streamline and consolidate their
offerings," Kelsay said, noting that the ecosystem of solutions that
employers have at their disposal is "far too extensive."
Employers are also
turning to their health plan and PBM partners to figure out how to finance and
manage high-cost therapies, NBGH President and CEO Brian Marcotte said at the
briefing. The survey revealed that such high-cost therapies — like Novartis'
$2.1 million spinal muscular atrophy drug, Zolgensma — are employers' No. 1
concern when it comes to managing their pharmacy benefit plans.
So how can health plans
and PBMs meet employers' desire for more help driving health care change?
They "can be
proactive in reaching out to their clients to engage them on emerging trends
and opportunities and propose solutions, rather than waiting for their clients
to approach them," Marcotte tells AIS Health via email.
No comments:
Post a Comment